VTGN Competitors & Alternatives
Compare VistaGen Therapeutics Inc with similar stocks in the same industry
Biotechnology
VTGN
Main Stock$0.59
Tradestie Score
52
Market Cap
$108.92M
Revenue Growth
0.3%
Analyst Upside
+64.6%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.57
|
$170.45M | - | 48 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.36
|
$158.43M | - | 59 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.60
|
$133.50M | - | 56 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$20.92
|
$110.20M | - | 54 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.53
|
$71.69M | - | 59 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.38
|
$67.94M | - | 54 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$33.20
|
$62.81M | - | 49 | Compare |
|
OTLK
Outlook Therapeutics, Inc. Common Stock
|
$1.18
|
$46.20M | - | 55 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$11.45
|
$34.77M | - | 55 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$3.25
|
$4.78M | - | 50 | Compare |
More VTGN Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry